Feb 28 2024 22 mins
Data is critical to the development of healthcare and life sciences. With thousands of clinical trials being performed worldwide, the amount of data is exponentially increasing. The problem is that 80% of healthcare data is unstructured - often coming in the form of documents of free text columns in tableau data sets. According to Lana Fend, Co-Founder and CEO of Huma.AI, the status quo is for professionals like herself to manually curate such data. Evidently, this process is largely labor-intensive and error-prone. Huma.AI combats these challenges by utilizing AI and natural language processing to automate data processing.
In doing so, Huma.AI expediates the process of bringing medicine to markets and saving thousands of lives. At the core of such efforts is the company's mission: to accelerate the development of life-saving drugs with a patient-centered approach. According to Lana, this warrants innovation at the speed of light. By using rapidly evolving AI technologies to automate the mundane tasks of data processing, healthcare experts can transform the industry.
A critical application of Huma.AI's work involves diversity and equity. By harnessing the power of AI, the company works to uncover data about disadvantaged populations and integrate it into clinical studies. This way, clinical trials can truly represent the general population, and drugs being developed can be equitably applicable to everyone.
#ideagen #aihealthtechandfinancesummit #huma.ai
Watch the entire 2024 AI, Health, Tech, and Finance Summit here: https://www.ideagenmember.com/2024miami
Learn more about the Huma.AI: https://www.huma.ai/
Lana's LinkedIn: https://www.linkedin.com/in/lanafeng/